Skip to content
Open access

Gastrointestinal bleeding in hepatocellular carcinoma under systemic therapy: Real-world incidence and clinical predictors

Jan 2026 · Clinics · Vol 81 · 0 citations · 28 references
Medicine

Abstract

Highlights • GI bleeding occurred in 24.1% of HCC patients during systemic therapy.• GI bleeding reached 23.1% cumulative incidence at 12-months.• Varices, splenomegaly and vascular invasion predicted bleeding risk.• A simple 4-point score stratified GI bleeding risk during treatment.• GI bleeding was associated with 75.5% bleeding-related mortality.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.